News
Gold Reserve Announces US$7.382 Billion Citgo Bid Recommendation
Gold Reserve Ltd. (TSX.V: GRZ) (OTCQX: GDRZF) announced today that its U.S. acquisition subsidiary, Dalinar Energy Corporation, is the Final Recommended Bidder for the purchase of shares of PDV
NiCE Unveils 2025 International CX Excellence Award Winners, Spotlighting the Game-Changers in AI-Driven Customer Service Automation
NiCE (Nasdaq: NICE) today announced the winners of its 2025 International CX Excellence Awards, honoring organizations from across EMEA and APAC that are redefining customer service with NiCE’s
EQS-News: PWO Group opens new site in Serbia, providing strong growth momentum for sustainable mobility
Halfords Group PLC: Director/PDMR Shareholding
EQS-News: MS Industrie AG: Annual General Meeting with positive outlook
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Anemoi International Ltd: Appointment of Director
EQS-News: wienerberger increases its stake in French GSEi to 100% and expands its position in the PV market
Coinsilium Group Limited: Result of Accelerated Bookbuild with £2,787,500 Raised
EQS-News: Management board adjusts forecast for financial year 2024/25
EQS-Adhoc: Management board adjusts forecast for financial year 2024/25 and approves new share buyback programme
EQS-News: DATAGROUP expands digitalization of student finance in Hesse
Evolva Holding SA invites to an Extraordinary General Meeting 2025 to change name to EvoNext Holdings SA
Aperam update on Q2 2025 market & financial trends
Oceaneering Announces Dates for Second Quarter 2025 Earnings Release and Conference Call
Oceaneering International, Inc. (“Oceaneering”) (NYSE:OII) announces that it will report financial results for the second quarter of 2025 on Wednesday, July 23, 2025, after the close of trading on
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on July 1, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement
Broadstone Net Lease Schedules Second Quarter 2025 Earnings Release and Conference Call
Broadstone Net Lease, Inc. (NYSE: BNL) (“Broadstone,” “BNL,” the “Company,” “we,” “our,” or “us”), today announced that it will release its financial and operating results for the quarter ended
Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions
Dyadic International, Inc. (“Dyadic”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered input proteins for non-therapeutic
Franklin Covey Reports Third Quarter Fiscal 2025 Financial Results
Franklin Covey Co. (NYSE: FC), a leader in organizational performance improvement that creates and distributes world-class content, training, processes, and tools that organizations and individuals
Expro Announces Inducement Grant Under NYSE Rule 303A.08
Energy services provider Expro Group Holdings N.V. (NYSE: XPRO) (the “Company”) today announced that effective June 30, 2025, the Compensation Committee of its Board of Directors granted equity
GrafTech Announces Second Quarter 2025 Earnings Conference Call and Webcast
GrafTech International Ltd. (NYSE:EAF) (the “Company”) will hold its Second Quarter 2025 Earnings Conference Call and Webcast on Friday, July 25, 2025 at 10:00 a.m. (EDT). The call will be hosted
BrightSpire Capital, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call Dates
BrightSpire Capital, Inc. (NYSE: BRSP) (“BrightSpire Capital” or the “Company”) today announced it will release second quarter 2025 financial results on Tuesday, July 29, 2025, after the market
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 119,860
Hoffmann Green Announces a Historic Increase in Production Over the First Half of 2025, Already Outperforming the Annual Volumes Realized in 2024
Hoffmann Green Cement Technologies (ISIN: FR0013451044, Ticker: ALHGR) (“Hoffmann Green Cement” or the “Company”), an industrial player committed to the decarbonation of the construction sector



